Authors
Esra Keles, Mustafa Maraşlı, Meziha Taşyurek, Elif Unlugedik Sayın, Öncel İpekçi, Mervenur Şahin, Ugur Kemal Öztürk, Fatih Şanlıkan, Murat Api
Published in
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. Volume 48. Epub Oct 30, 2026.
Abstract
To investigate the clinicopathological significance and prognostic impact of lymphovascular space invasion (LVSI) within the mismatch repair-deficient (MMRd) molecular subgroup of endometrial cancer.
A retrospective study was conducted on patients with histologically confirmed endometrial carcinoma who underwent primary surgical staging between January 2017 and December 2020. Immunohistochemical analysis of mismatch repair proteins (MLH1, MSH2, MSH6, and PMS2) was performed to classify tumors into MMR-proficient or MMR-deficient (MMRd) subgroups. LVSI status was independently reviewed and classified as absent, focal, or substantial by two gynecologic pathologists. Clinicopathologic findings and follow-up data were extracted from the institutional electronic medical records.
A total of 214 patients with a mean age 60.61±9.70 years were included, with a median follow-up of 24.6 months (IQR: 24.7 months). Fifteen death events (7.0%) were recorded during the study period. LVSI was identified in 42 patients (19.6%), including 26 with focal and 16 with substantial involvement. LVSI-positive tumors were significantly associated with larger tumor size (p<0.001), high-grade histology (p<0.001), non-endometrioid subtype (p<0.001), lymph node metastasis (p<0.001), and advanced FIGO stage (p<0.001). Among the 70 patients (32.7%) with MMRd tumors, LVSI was observed in 14 cases (20.0%) and remained significantly associated with aggressive features, including larger tumor size (p <0.001), high-grade histology (p = 0.010), advanced stage (p = 0.011), and lymph node involvement (p <0.001). However, overall survival did not differ significantly between LVSI-positive and LVSI-negative MMRd patients (log-rank p = 0.213).
LVSI is associated with adverse clinicopathologic features in endometrial cancer, including within the MMRd molecular subgroup. However, its presence does not appear to independently influence overall survival in MMRd patients.
PMID:
43017603
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0